Systemic lupus erythematosus is an immune-mediated syndrome in which the immune response is to noneorgan-specific antigens, and virtually every organ in the abdominal cavity may become involved. Only renal involvement forms part of the diagnostic criteria, however, a combination of typically nonspecific findings, including peritoneal surface, enteric, renal, renal tract, pancreatic, adrenal, hepatobiliary, and splenic manifestations, should be looked for in patients with known lupus or other connective tissue disease who are undergoing abdominal imaging and may suggest the diagnosis in patients presenting with an acute abdomen. Our work presents the spectrum of imaging findings of abdominal manifestations of systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) is a disease of unknown etiology in which tissues and cells are damaged by pathogenic auto-antibodies and immune complexes. Up to 90% of affected patients are female. The clinical course is characterized by remissions and exacerbations, with mucocutaneous, cardiorespiratory, renal, and neurologic manifestations. Despite established diagnostic criteria (Table 1 ) [1] , many patients with SLE also demonstrate features of other connective tissue diseases, such as dermatomyositis or systemic sclerosis.
Abdominal manifestations may result from primary involvement with SLE or from complications of therapy and are well documented in the rheumatology literature [2e5] . Serositis and intestinal vasculitis can present with severe abdominal pain and may masquerade as an acute surgical abdomen. Small and large bowel ischemia may result from vasculitis or vascular occlusion associated with the antiphospholipid syndrome. Renal involvement is common and forms part of the diagnostic criteria ( Table 1 ). The liver, spleen, pancreas, adrenals, and genitourinary tract may also become involved [2e4] .
While the imaging appearances are typically nonspecific, retrospective reviews suggest a diagnostic role for computed tomography (CT) in patients with lupus enteritis [6e8]. Peritoneal surface, renal, renal tract, adrenal, hepatobiliary, pancreatic, and splenic manifestations should be looked for in patients with known lupus or other connective tissue disease undergoing abdominal imaging and may suggest the diagnosis in a patient presenting with an acute abdomen.
Our work reviews the spectrum of imaging findings of abdominal manifestations of SLE.
Serositis
Ascites occurs in approximately 10% of patients with SLE ( Figure 1 ). Possible causes include serositis, pancreatitis, nephritis and nephrotic syndrome, constrictive pericarditis, and peritoneal inflammation secondary to vasculitis. Chylous ascites is particularly unusual (Figure 2 ) [9] . Ascites is an infrequent finding in patients with lupus nephritis and, when present, is more likely to be due to peritoneal serositis than hypoalbuminemia.
Serositis can develop when SLE is inactive but may also manifest as peritonitis that may mimic an acute surgical abdomen and lead to exploratory laparotomy. Low et al [10] reported the characteristics of lupus serositis on barium small bowel series as showing segments of spiculation with tethering, angulation, and obstruction. CT demonstrated ascites and asymmetric thickening of the small bowel wall. Laparotomy showed extensive patchy serosal and peritoneal plaques, but biopsies did not reveal any specific lesions [10] .
Similar to vasculitis, ascites and serositis typically resolve with high-dose steroid therapy [8] .
Enteric Manifestations
Gastrointestinal (GI) involvement in SLE may be easily overlooked since many GI symptoms can be attributed to complications of drug therapy, such as nonsteroidal antiinflammatory drugs, steroids, and azathioprine. Involvement of the GI tract in SLE is almost always accompanied by evidence of active disease in other organs, although occasionally it may be the main clinical feature [2] .
Mouth ulcers may occur in up to 50% of patients with SLE [3] . Mucosal ulcers usually occur in the hard palate, buccal mucosa, or the vermilion border, and may be erythematous and painless, or discoid and painful, causing dysphagia or odynophagia [4] .
Dysphagia may be secondary to a lack of saliva for mastication as seen in Sjögren syndrome, infection, or esophageal dysmotility. Tertiary contractions, impaired esophageal emptying and/or esophageal dilatation may be seen on barium upper-GI series, and manometry may .0 Â 10 9 /L on 2 or more occasions or c) Lymphopenia <1.5 Â 10 9 /L on 2 or more occasions or d) Thrombocytopenia: <100 Â 10 9 /L 10. Immunologic disorder a) Positive LE cell preparation or b) Anti-DNA: antibody to native DNA in abnormal titer or c) Anti-Sm: presence of antibody to Sm nuclear antigen or d) False-positive serologic test for syphilis known to be positive for at least 6 mo and confirmed by Treponema pallidum immobilization or fluorescent treponemal antibody absorption test 11. Antinuclear antibody An abnormal titer of antinuclear antibody by immunofluorescence or an equivalent assay at any point in time and in the absence of drugs known to be associated with ''drug-induced lupus'' syndrome demonstrate decreased esophageal peristalsis and decreased lower esophageal sphincter pressure, leading to reflux, although severe involvement of the lower esophageal sphincter is much more common in those patients with clinical and serologic overlap with systemic sclerosis [3] . Such patients may demonstrate esophageal dilatation ( Figure  1 ). Systemic vasculitis that involves the esophagus and stomach may result in ulceration and perforation. ''Watermelon stomach,'' or gastric antral vascular ectasia, has a well-recognized association with autoimmune disorders and has been reported in association with SLE. Peptic ulceration with perforation was reported by Medina et al [11] in 5.8% (3/55) patients with SLE who presented with an acute abdomen. The role of nonsteroidal anti-inflammatory agents in causing these perforating ulcers was unclear.
Protein-losing enteropathy is an unusual presentation. Hizawa et al [12] described the double-contrast radiographic features in 6 patients with lupus-associated enteropathy. Two patients had protein-losing enteropathy with hyperlipidemia, characterized by mildly thickened folds with multiple submucosal nodules in the upper portion of the jejunum. In one patient from this group, jejunal biopsy demonstrated lymphangiectasia. Four patients had acute-onset enteritis with irregular thickening and spiculation in the folds of multiple segments from the duodenum to the terminal ileum, accompanied by thumbprinting, suggestive of ischemic change [12] . The association of SLE with inflammatory bowel disease is unusual. A rare case of colonic carcinoma in a patient with lupus and with collagenous colitis has been reported [13] .
Chronic intestinal pseudo-obstruction is an uncommon complication of SLE, characterized by ineffective intestinal propulsion. It may reflect a dysfunction of visceral smooth muscle or the enteric nervous system [14] . In a series of 5 patients, Perlemuter et al [14] described imaging findings of dilated, fluid-filled bowel loops and bilateral ureteral dilatation, with a reduced urinary bladder capacity. In one patient, histology showed normal innervation of the bowel wall but with a marked fibrotic process in the muscularis layer. Gastric scintigraphy showed delayed emptying. There was manometric evidence of small bowel hypomotility with reduced amplitude of contractions during phase III and infrequent contractions during phase II of the migrating motor complex [14] . Similar findings of dysmotility have also been reported in patients who have overlap features with scleroderma ( Figure 3 ) and related disorders.
Vasculitis
Vasculitis in SLE may involve any part of the GI tract from the esophagus to the rectum, although there is a tendency for the vasculitis to affect the distribution of the superior mesenteric artery [15] . Other causes of vascular insufficiency should be considered before a diagnosis of lupus vasculitis is made. For example, immunotherapy may be associated with cytomegalovirus (CMV) and other infections, leading to colitis. Thrombosis of mesenteric vessels associated with the antiphospholipid syndrome (up to a third of patients with SLE have antiphospholipid antibodies) can give rise to visceral or mesenteric ischemia and bowel infarction (Figures 4 and 5) [16] .
The exact incidence of lupus vasculitis in the GI tract is unknown. Literature review indicates that clinically apparent bowel vasculitis occurs in fewer than 5% of patients with SLE. Ramos-Casals et al [17] reviewed the prevalence of vasculitis in 670 patients with SLE. Small arteries and venules of the skin were the most common vessels involved, typically associated with increased disease activity scores. Medium vessel vasculitis was diagnosed on histology in one patient with pancreatic involvement and in one patient with gallbladder involvement. No bowel involvement was reported, and no details of imaging investigations were provided [17] . Drenkard et al [18] reported only one case of mesenteric vasculitis in 540 patients with SLE. The true incidence of vasculitis may be higher than these articles suggest, as involvement may range from clinically quiescent to mild colitis with diarrhoea, to mucosal ulceration with hemorrhage, to intestinal infarction and perforation. Although less common than involvement in the small bowel, necrotizing vasculitis and perforating ulceration of the appendix, transverse colon, splenic flexure, sigmoid colon, and rectum in patients with SLE have been documented [19e21] . Vasculitis that involves intra-abdominal vessels can result in aneurysmal dilatation and hemorrhage from visceral arteries. The abdominal aorta may rarely be affected.
There are several scoring systems for assessment of disease activity in lupus that measure laboratory indices and variably include organ weighting, antiedouble-stranded DNA, complement, and assessment of fatigue [22] . The SLE disease activity index (SLEDAI) is most commonly used, but there are discordant reports regarding its usefulness as a predictor of underlying enteritis in patients with acute abdominal pain [23, 24] . 
Imaging Features
Vasculitis that affects the bowel typically appears as circumferential, symmetric multisegmented bowel wall thickening (Figures 6e8), primarily of the jejunum and ileum, of variable length. It typically involves more than one vascular territory [8, 25] . CT findings in patients with lupus mesenteric vasculitis that causes ischemic bowel include engorgement of mesenteric vessels with a palisade pattern or comb-like appearance; focal or diffusely dilated bowel loops (>3 cm); ascites with increased peritoneal enhancement; thickening of the small bowel, with a target sign; and increased attenuation of mesenteric fat (Figure 7 ) [7, 8] . Kim et al [26] suggested that bowel wall thickness !9 mm should be considered a high-risk factor for recurrent enteritis.
Si-Hoe et al [6] reported nonspecific small bowel thickening in 55% (30/54) and nonspecific colonic wall thickening in 9% of patients with SLE (5/54) who underwent abdominal CT for a variety of GI complaints. Clear evidence of ischemic bowel disease as described by Byun et al [7] was seen in only 2 patients [6] .
Kwok et al [23] diagnosed lupus enteritis in 47% of patients with lupus (41/87) admitted to the hospital with acute abdominal pain (excluding renal colic) over a 16-year period. Clinical relapse occurred in 31% of patients after a mean of 24 months. In 77% of clinical episodes, bowel wall involvement was multisegmental and not confined to a single vascular distribution. Autoantibody, including antiphospholipid, profiles were similar between patients with enteritis and other causes of abdominal pain. Elevated SLEDAI scores were consistent with active disease stage, and most patients responded well to high-dose steroids [23] .
Lian et al [27] retrospectively reviewed 52 patients with SLE admitted with acute abdominal symptoms. Abdominal pain (87%), vomiting (82%), and diarrhoea (67%) had been present for a mean of 4.4 days, and the SLEDAI score was elevated in 83% of patients. CT showed evidence of serositis Figure 5 . Coronal portal phase computed tomography, demonstrating acute superior mesenteric vein (SMV) thrombosis (arrow). The splenic vein is patent (asterisk). Note the calcification in the splenic, portal, and superior mesenteric veins from previous episodes of thrombosis. There is also nonspecific colonic wall thickening in this patient. and bowel involvement in 63% of patients who underwent this investigation. Parenteral steroids were used in 90% and intravenous cyclophosphamide in 31% of patients. Most patients (98%) were discharged in good condition. Recurrence of GI symptoms occurred in 23% of the patients [27] .
Buck et al [28] retrospectively compared 56 patients with SLE admitted with predominantly subacute abdominal pain (without peritoneal signs) with 56 age-and sex-matched ''controls'' (patients without SLE admitted with abdominal pain). Intestinal vasculitis was diagnosed in 5.4% of patients with SLE compared with 0% of control patients (P < .05). Only patients with SLEDAI scores >8 developed vasculitis (P < .001), and the authors recommend restricting the use of CT to diagnose vasculitis in patients with subacute abdominal pain to those with SLEDAI scores >8 [28] . In contrast, al-Hakeem and McMillen [29] recommended routine use of CT in all patients with lupus and abdominal pain on steroids to exclude perforated viscus. Buck et al [28] recommended the routine use of CT to diagnose vasculitis in patients with subacute abdominal pain only when SLEDAI scores were >8.
Medina et al [11] correlated SLEDAI scores and the cause of acute abdomen in 51 patients with SLE. Patients with intra-abdominal vasculitis (19 patients) or thrombosis (3 patients) had higher SLEDAI scores than patients with active SLE and non-SLE related acute abdomen (14 patients) (mean scores 17.5 vs 8.2). Fifteen patients with inactive SLE (SLEDAI 1.7) had intra-abdominal pathology that was diverse and not related to lupus. The investigators emphasize early laparotomy in patients with active SLE with high SLEDAI scores and an acute abdomen because the mortality in this subgroup was very high [11] .
In contrast, a retrospective study by Lee et al [24] found no difference in age, sex, antibody profile, ESR, C-reactive protein, or SLEDAI between patients with lupus enteritis, diagnosed by clinical investigation and abdominal CT findings (n ¼ 17) and those with other causes of abdominal pain (n ¼ 21), although patients with enteritis were more likely to be neutropenic [24] .
Intramural gas (pneumatosis intestinalis) is uncommon but may be seen in association with severe ischemia and with necrotizing enterocolitis [3] . Although the outcome of intestinal perforation secondary to lupus vasculitis is extremely poor, generally the imaging appearance in lupus enteritis is worse than the symptoms, and CT findings typically reverse after prompt administration of high-dose steroids [7, 8, 24, 25] .
Urinary Tract
Proteinuria is the most common renal manifestation and usually presents within the first 5 years after diagnosis. Microscopic hematuria is also almost always present, whereas macroscopic hematuria is rare. Clinical lupus nephritis is one of the major causes of morbidity and mortality in patients with SLE and is observed in up to 60% of patients [30] .
Virtually all patients with SLE have histologic abnormalities, including electron microscopic and/or immunofluorescence evidence of immune complex deposits in the glomeruli; however, the overriding characteristic of lupus nephritis is its variability among patients, within biopsy specimens, and even within glomeruli [30] .
Imaging signs of renal involvement are nonspecific (Figure 9 ). The kidneys may be normal, increased, or decreased in size. Renal cortical echogenicity may range from normal to echogenic. Cortical nephrocalcinosis may be seen in end-stage disease (arrows, Figure 9H) . Other nonspecific features that should be considered include focal hematoma post biopsy, focal infarction, and scarring. Patients with SLE are at increased risk for renal vein thrombosis, particularly in patients in whom there is overlap with antiphospholipid antibody/syndrome ( Figure 10 ). Renal vein thrombosis should be excluded if a patient with SLE and with previously stable renal function develops rapidly increasing proteinuria, nephrotic syndrome, pedal oedema, or presents with deteriorating renal function [6] . Of the 65 CTs reviewed by Si-Hoe et al [6] , 52 were undertaken to rule out suspected renal vein or vena caval thrombosis; 13% of patients had renal vein thrombosis, 71% of whom also had thrombus in the IVC [6] . Renal biopsy is typically reserved for patients with hematuria and proteinuria or a fall in creatinine clearance. Histologic glomerular and tubulointerstitial features may be used to distinguish potentially reversible from chronic disease. Biopsy also excludes nonlupus kidney disease, such as renal thrombotic microangiopathy, drug-induced interstitial nephritis, focal segmental glomerulosclerosis, and IgA nephropathy, that may affect persons of similar age and sex. The World Health Organization classification, originally designated in 1982 and more recently evolved under the auspices of both the International Society of Nephrology and the Renal Pathology Society, has proven useful in prognostication as a guide to therapy [31] .
Urologic manifestations of SLE are uncommon and are typically associated with GI disorders such as diarrhoea, vomiting, malabsorption, ascites, and protein-losing enteropathy. Vasculitis-related lupus cystitis may cause a contracted bladder, with diffuse wall thickening and resultant hydronephrosis. Reduced bladder capacity may be secondary to detrusor muscle spasm caused by bladder inflammation, and immune complex deposition has been implicated. Diffuse bladder wall thickening was diagnosed in 15% (5/32) and bilateral hydronephrosis and hydroureter in 9% (3/32) of patients with SLE who presented with abdominal symptoms in a retrospective review of CT findings by Phongkitkarun et al [25] .
Min et al [32] diagnosed lupus cystitis in 5 of 413 patients with SLE (1.2%). Bilateral hydroureteronephrosis and thickened bladder wall were identified on abdominal ultrasound or CT. All patients with lupus cystitis showed GI manifestations, such as abdominal pain, nausea, vomiting, and/or diarrhoea, and abdominal CT revealed bowel wall thickening in 4 of the 5 patients [32] .
Chronic idiopathic intestinal pseudo-obstruction is known to be associated with urologic manifestations, and this association between cystitis and gut involvement in SLE may represent a distinct subgroup with a guarded prognosis, despite aggressive immunosuppression, although in many cases corticosteroids may reverse the inflammatory cystitis, normalize bladder capacity and ureteric distension, and improve bowel motility [14] .
Pancreas
Pancreatitis (Figures 11 and 12) is an uncommon initial presentation of SLE and occurs in approximately 5% of patients with SLE, often secondary to vasculitis [33] . Necropsy findings of severe intimal proliferation have been reported [33] .
In contrast to lupus enteritis, lupus pancreatitis, even in patients on steroid therapy, is usually symptomatic and almost always presents acutely, typically with a flare-up that involved multiple organs, although chronic pancreatitis has been reported.
Nesher et al [34] reviewed 77 patients (88% women, median age 27 years) with lupus pancreatitis. In 44% of patients, pancreatitis developed within 1 year of the diagnosis of lupus, and 84% had active lupus at the time of pancreatitis. Patients presented with abdominal pain (88%), followed by nausea and/or vomiting (67%). Pancreatitis was diagnosed on laboratory evidence of elevated serum amylase or lipase in 97% of patients. Abdominal CT and ultrasonography did not show signs of pancreatic involvement in 24% and 45%, respectively. The mortality rate was 27%. Active lupus and some biochemical abnormalities were significantly associated with increased mortality. Patients treated with corticosteroids or azathioprine after the onset of pancreatitis had a 20% mortality compared with 61% among those not treated (P ¼ .005) [34] .
The pathogenesis of pancreatitis in patients with SLE is controversial. Saab et al [35] found no role for steroids in the pathogenesis of pancreatitis in SLE. Pascual-Ramos et al [36] , over a 7-year period, reviewed 49 episodes of acute pancreatitis (AP) in 35 patients with SLE. Prevalence was estimated at 3.5%. Identified AP causes were mechanical in 28% and toxic metabolic, including steroids, in 20%. Idiopathic AP was more frequent in SLE cases (46%) than in non-SLE ''controls'' (14%). The strength of association of AP severity and related mortality was higher in patients with SLE than in non-SLE controls (odds ratio 8.6 and 7.5, respectively) [36] .
Adrenal
Adrenal hemorrhage ( Figure 13 ) and hypoadrenalism ( Figure 14 ) are well-recognized manifestations of both SLE and primary antiphospholipid syndrome, and should be excluded in such patients who complain of abdominal pain and undue weakness or asthenia. Similarly, screening for lupus anticoagulant and anticardiolipin antibodies has been recommended in all cases of adrenal hemorrhage or infarction [37] .
Liver
Active liver disease is rare in SLE. Abnormal liver function tests occur in up to 50% of patients, usually secondary to medication, such as nonsteroidal anti-inflammatory drugs or azathioprine [38] . Antiphospholipid antibodies in SLE may be associated with the Budd-Chiari syndrome and present with abdominal pain, ascites, or hepatic failure because of thrombosis of the portal vein and hepatic veins ( Figure 15 ).
Hepatomegaly, steatosis, chronic active hepatitis, granulomatous hepatitis, cholestasis, centrilobular necrosis, microabscesses, cirrhosis, including primary biliary cirrhosis and hemochromatosis, have all been reported in association with SLE.
Hepatitis in patients with SLE is associated with autoantibodies such as anti-dS DNA and antiribosomal P, and is most likely to be lobular. In contrast, autoimmune hepatitis is more likely to be periportal (chronic active hepatitis), with rosetting of liver cells and dense lymphoid infiltrates; it often has specific autoantibodies to antieliver-specific protein or antieliver-kidney-microsomal antibody. Both conditions are associated with features of autoimmunity, such as polyarthralgia, hypergammaglobulinemia, and a positive antinuclear antibody (ANA). Autoimmune hepatitis is more prevalent in patients with juvenile lupus. Necrotizing vasculitis can affect the gall bladder and the bile ducts, and may present as acalculous cholecystitis or benign biliary stricture [39] .
Spleen
Hyposplenism is infrequently described in patients with SLE (up to 5% of patients) and is thought to be caused by vasculitic changes within the spleen. A diagnosis of hyposplenism can easily be made by identifying Howell-Jolly bodies on a peripheral blood smear. Multiple small asymptomatic calcifications of the spleen have been reported in isolated cases and may be directly related to the connective tissue disease (Figure 16 ) [40, 41] ; however, there is a myriad of potential causes for multiple splenic calcifications, for example, granulomatous disease, particularly in areas endemic for histoplasmosis, and correlation with clinical history is required. In SLE, the small penicillar arteries of splenic pulp typically develop concentric perivascular laminations of fibrous tissue to produce the typical ''onion skin'' lesion, which is characteristic of, but no longer regarded as specific for, SLE. Splenic infarction ( Figure 12B, asterisk) is not uncommon.
Pediatric Patients
The GI manifestations in childhood-onset SLE are outside the scope of this article. Interested readers are referred to the recent review on this subject by Richer et al [5] .
Infective Complications
The nonspecific appearances of intra-abdominal infection should not be overlooked in imaging the abdomen in patients with SLE. Not only does the disease itself affect the immune Figure 14 . Axial computed tomography, demonstrating nonvisualization of the adrenal glands in a patient with lupus and with a remote history of adrenal hemorrhage that resulted in adrenal insufficiency. demonstrated the absence of flow in the right hepatic vein. Hepatic venography confirmed a web at the right hepatic venous exit (arrow in C). Transjugular biopsy, was followed by angioplasty of the web with symptomatic improvement. system, but, in addition, many of the drugs used to treat SLE also alter immune status, and opportunistic infections are, therefore, more common. Heiberg et al [42] reported that mild lymphadenopathy was the most frequent finding in a review of 55 CTs in 27 patients with SLE who were undergoing CT for a variety of indications, particularly for suspected intraabdominal sepsis. Enlarged, centrally hypoattenuating retroperitoneal lymph nodes ( Figure 3B ) have been previously described in SLE without associated infection [43] , however, infection, particularly mycobacterial, should form part of the differential diagnosis.
Conclusion
SLE can involve any organ or region of the abdomen. The authors recommend an organ-and/or systems-based approach to imaging. Although abdominal symptoms in lupus are most likely to be due to of the same conditions as those found in patients without lupus, a spectrum of abdominal imaging findings, including involvement of the peritoneal surfaces, GI tract, kidney, pancreas, adrenals, liver, and spleen, along with systemic vascular involvement, should be looked for in patients with known lupus or other connective tissue disease undergoing abdominal imaging and may suggest the diagnosis in a patient presenting with an acute abdomen.
